Pharmafile Logo

The Social Dilemma

- PMLiVE

In the June issue of PME, Dennis O’Brien, Lucid CEO, explores the relationship between social media and pharma.

“There is a party going on next door, but our industry is too scared to go in,” comments Dennis.

The way the world communicates has changed radically over the last 15 years, but pharma simply isn’t configured to take advantage of this shifting landscape. Other industries are building infrastructure to leverage this enormous channel, but pharma is still reliant on the traditional communication routes, held back by the fear of regulations and the level of investment it will take.

Dennis concludes, “We’re scared to go to the party. We must move from being scared to being real.”

Read more about what Dennis and other industry thought leaders have to say on the role of social media in pharma here.

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD

Lucid Group’s new website is launched!

Lucid Group unveil new website...

He who dares wins

The benefits of including medical experts in your brand planning team

Does your medical education drive change in clinical practice?

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Advance the way you work with your experts

Written by Jan Steele PhD, operations director, Lucid